Daratumumab HS Code Trade Classification — 14 Codes, $350.8M Trade

Q: How much Daratumumab is exported under HS code 30021500?

Under HS code 30021500, India exports $349.5M worth of Daratumumab, representing 99.6% of total Daratumumab trade. This involves 61 shipments from 12 Indian exporters to 13 buyers in 13 countries.

Q: Which countries import the most Daratumumab from India?

The top importing countries for Daratumumab from India are Brazil, Cayman Islands, Oman. The leading importer Brazil accounts for $613.3K in trade value. In total, Daratumumab is exported to buyers across multiple countries under 14 HS code classifications.

Q: Who are the top Daratumumab exporters from India?

The leading Daratumumab exporters from India include JANSSEN PHARMACEUTICA N.V. ($338.4M), JANSSEN PHARMACEUTICA N.V. ($8.2M), JANSSEN PHARMACEUTICA N V ($2.7M). These suppliers export across multiple HS code classifications with a combined trade value of $350.8M.

TransData Nexus

Daratumumab

India Pharmaceutical Trade Intelligence

$1.3M36 Suppliers23 CountriesHS 30049099

ExportsIndia → BRAZIL45.9%India → CAYMAN ISLANDS9.4%

ImportsSWITZERLAND → India$344.4M BELGIUM → India$4.9M

#1 Supplier: VAMA LIFECARE #1 Buyer: AS PER

Daratumumab HS Codes (2026) — 14 Classifications, $350.8M Trade | TransData Nexus | TransData Nexus

Daratumumab HS Code Analysis (2026)

India exports Daratumumab under 14 distinct HS code classifications, representing a total trade value of $350.8M across 284 shipments. The dominant classification is HS 30021500 (Immunological products, put up in measured doses or for retail sale), accounting for 99.6% of all Daratumumab trade at $349.5M. HS 30049099 (Other medicaments, put up in measured doses or for retail sale) follows at 0.3% ($882.2K). The top 5 HS codes together account for 100.0% of total Daratumumab trade from India. The average transaction value is $1235139. Key importing markets include Brazil, Cayman Islands, Oman. Leading exporters include JANSSEN PHARMACEUTICA N.V. and JANSSEN PHARMACEUTICA N.V.. Data sourced from Indian Customs (DGFT) shipping bill records.

Daratumumab HS Code Analysis — 14 classifications, $350.8M trade value, top HS codes breakdown and distribution — Daratumumab HS code analysis — 14 classifications · $350.8M trade value · 284 shipmentsTransData Nexus · Indian Customs Data

Top Daratumumab HS Code Classifications

Ranked by trade value from Indian Customs (DGFT) data

Rank	HS Code	Trade Value	Share	Transactions	Avg Price	Suppliers	Countries
#1	30021500	$349.5M	99.6%	61	$47667.37	12	13
#2	30049099	$882.2K	0.3%

HS 30021500

Immunological products, put up in measured doses or for retail sale · 99.6% of Daratumumab trade

$349.5M

Trade Value

99.6%

Market Share

Transactions

$47667.37

Avg Unit Price

Suppliers: 12Buyers: 13Countries: 13

Common Product Descriptions:

DARATUMUMAB 1800 MG ING BRAND NAME : DARZALEX FASP...

DARATUMUMAB 1800 MG ING BRAND NAME: DARZALEX FASPR...

DARZALEX FASPRO 1800MG DARATUMUMAB LIQUID FOR INJE...

HS 30049099

Other medicaments, put up in measured doses or for retail sale · 0.3% of Daratumumab trade

$882.2K

Trade Value

0.3%

Market Share

168

Transactions

$1237.26

Avg Unit Price

Suppliers: 43Buyers: 50Countries: 34

Common Product Descriptions:

DARATUMUMAB INJECTION 400MG / 20ML BRAND

DARZALEX 100 ( DARATUMUMAB CONCENTRATE F

DARZALEX 400 ( DARATUMUMAB CONCENTRATE F

HS 30044990

Other medicaments containing alkaloids or derivatives (retail) · 0.0% of Daratumumab trade

$165.0K

Trade Value

0.0%

Market Share

Transactions

$696.22

Avg Unit Price

Suppliers: 1Buyers: 3Countries: 2

Common Product Descriptions:

HARMLESS MEDICINE FOR HUMAN CONSUMPTIONDARATUMUMAB...

HS 30019091

Human placental extract · 0.0% of Daratumumab trade

$102.1K

Trade Value

0.0%

Market Share

Transactions

$3404.82

Avg Unit Price

Suppliers: 1Buyers: 1Countries: 1

Common Product Descriptions:

HARMLESS MEDICINE FOR HUMAN USE DARATUMUMAB LIQUID...

HS 30049099

Other medicaments of mixed or unmixed products (retail) · 0.0% of Daratumumab trade

$54.3K

Trade Value

0.0%

Market Share

Transactions

$1068.01

Avg Unit Price

Suppliers: 5Buyers: 7Countries: 3

Common Product Descriptions:

ASPER INVOICE NO: ZPPL/XP/2425/011 DATE:01/04/2024...

MEDICINES:EACH VIAL OF 15 ML CONCENTRATECONTAINS:D...

MEDICINES:EACH VIAL OF 20 ML CONCENTRATE:DARATUMUM...

HS 30043990

Medicaments containing other hormones (retail) · 0.0% of Daratumumab trade

$19.3K

Trade Value

0.0%

Market Share

Transactions

$2417.30

Avg Unit Price

Suppliers: 1Buyers: 2Countries: 1

Common Product Descriptions:

DARATUMUMAB LIQUID FOR INJECTION- 1800MG (BATCH NO...

DARATUMUMAB LIQUID FOR INJECTION 1800MG (BATCH NO-...

HS 30049029

Other analgesics and antipyretics, put up for retail sale · 0.0% of Daratumumab trade

$8.4K

Trade Value

0.0%

Market Share

Transactions

$837.91

Avg Unit Price

Suppliers: 1Buyers: 2Countries: 2

Common Product Descriptions:

[TAX DOCUMENT NO. WH02802; GSTIN. 27AACCN8725E1ZF]...

[TAX INV.NO. WH04475; GSTIN. 27AACCN8725E1ZF] DARA...

HS 30049095

Dermatological preparations, put up for retail sale · 0.0% of Daratumumab trade

$7.9K

Trade Value

0.0%

Market Share

Transactions

$246.34

Avg Unit Price

Suppliers: 1Buyers: 1Countries: 1

Common Product Descriptions:

Abemaciclib 150 Mg Each vial of 20mL concentrate c...

HS 30021290

Other antisera and blood fractions · 0.0% of Daratumumab trade

$6.1K

Trade Value

0.0%

Market Share

Transactions

$1152.29

Avg Unit Price

Suppliers: 2Buyers: 2Countries: 1

Common Product Descriptions:

Laboratory reagents and kits for Manufacturing in ...

ANTI- DARATUMUMAB ANTIBODY (11F2), MAB, MOUSE RECO...

#10

HS 30

Pharmaceutical product (Chapter 30) · 0.0% of Daratumumab trade

$1.2K

Trade Value

0.0%

Market Share

Transactions

$410.00

Avg Unit Price

Suppliers: 1Buyers: 1Countries: 1

Common Product Descriptions:

DARATUMUMAB (DARZALEX) 100 MG/5ML (TEST LIC: TL/AZ...

#11

HS 30021300

Immunological products, unmixed, not put up in measured doses · 0.0% of Daratumumab trade

$1.2K

Trade Value

0.0%

Market Share

Transactions

$11.89

Avg Unit Price

Suppliers: 2Buyers: 2Countries: 2

Common Product Descriptions:

P33 BULK HARVEST MATERIAL,BATCHNO.P33-ENGG-01 (Dar...

(N.C.V) DARATUMUMAB GENERATION 1 REFERENCE (FOR NI...

#12

HS 30045090

Other medicaments containing vitamins or provitamins (retail) · 0.0% of Daratumumab trade

$1.1K

Trade Value

0.0%

Market Share

Transactions

$18.65

Avg Unit Price

Suppliers: 1Buyers: 1Countries: 1

Common Product Descriptions:

MEDICINES FOR CONSUMPTION AND THE DESCRIPTION OF T...

#13

HS 30029090

Other blood products, toxins, cultures of micro-organisms · 0.0% of Daratumumab trade

$488

Trade Value

0.0%

Market Share

Transactions

$77.20

Avg Unit Price

Suppliers: 2Buyers: 2Countries: 2

Common Product Descriptions:

DARATUMUMAB MCB (BATCH NO:P33-MCB-0001)MFG. DATE :...

DARATUMUMAB MCB (BATCH NO: P33-MCB-0002)Mfg. Date ...

Anti-Daratumumab Antibody (FOR RESEARCH PURPOSE ON...

#14

HS 30021400

Immunological products, mixed, not put up in measured doses · 0.0% of Daratumumab trade

$278

Trade Value

0.0%

Market Share

Transactions

$139.18

Avg Unit Price

Suppliers: 1Buyers: 1Countries: 1

Common Product Descriptions:

Anti-Daratumumab Antibody mAb Mouse FOR RESEARCH U...

Where Daratumumab is Exported — Geographic HS Code Analysis

Import destinations for Daratumumab from India, by trade value

India exports Daratumumab to 10+ countries under 14 HS code classifications. The largest import destination is Brazil ($613.3K), followed by Cayman Islands ($125.7K) and Oman ($102.1K). These markets collectively account for the majority of India's Daratumumab pharmaceutical exports.

Rank	Country	Trade Value	Market Share
#1	Brazil	$613.3K	0.2%
#2	Cayman Islands	$125.7K	0.0%
#3	Oman	$102.1K	0.0%
#4	Zimbabwe	$60.7K	0.0%
#5	Georgia	$59.1K	0.0%
#6	Mauritius	$55.1K	0.0%
#7	Iraq	$55.0K	0.0%
#8	British Virgin Islands	$54.6K	0.0%
#9	Seychelles	$42.8K	0.0%
#10	United Arab Emirates	$35.3K	0.0%

Pharmaceutical buyers in these markets import Daratumumab primarily under HS code 30021500 (Immunological products, put up in measured doses or for retail sale). Import duties, regulatory requirements, and product registration vary by destination country. Contact TransData Nexus for country-specific import intelligence.

Understanding Daratumumab HS Codes

The Harmonized System (HS) is an internationally standardized system of names and numbers to classify traded products. Developed by the World Customs Organization (WCO), it is used by over 200 countries for customs tariffs, trade statistics, and regulatory compliance. Each HS code is a 6-digit number (extended to 8 digits in India's Customs Tariff Schedule) that precisely identifies a product category.

How Daratumumab HS Codes Work

Daratumumab falls under Chapter 30 (Pharmaceutical Products) of the Harmonized System. The 14 codes used for Daratumumab exports span multiple headings:

Heading 3003 — Medicaments not put up in measured doses or for retail sale (bulk APIs, intermediates)
Heading 3004 — Medicaments put up in measured doses or for retail sale (finished formulations)
Heading 3005 — Wadding, gauze, bandages for medical use
Heading 3006 — Pharmaceutical goods (sutures, reagents, dental cements)

The most significant distinction for Daratumumab is between HS 3003 (bulk/unmeasured) and HS 3004 (retail-ready). HS 3004 codes account for the majority of Daratumumab trade (as finished formulations ready for dispensing). The 8-digit Indian Customs Tariff code further specifies the therapeutic class — for example, HS 30021500 refers to "Immunological products, put up in measured doses or for retail sale".

Regulatory & Compliance — Daratumumab Export Classification

Correct HS code classification is critical for Daratumumab exports from India. Misclassification can result in customs delays, incorrect duty assessment, and regulatory penalties. Key compliance considerations for pharmaceutical stakeholders:

Import Duty Classification

Daratumumab import duties vary significantly by HS code and destination country. HS 3004 (finished formulations) typically attracts different duty rates than HS 3003 (bulk APIs). Many developing countries offer preferential rates for essential medicines including Daratumumab.

DGFT & Indian Customs Requirements

Indian exporters must declare the correct 8-digit ITC-HS code on shipping bills filed with the Directorate General of Foreign Trade (DGFT). Daratumumab exports require Drug Controller General of India (DCGI) approval and must comply with Drug & Cosmetics Act regulations.

WHO Prequalification

For international procurement (UNICEF, Global Fund), Daratumumab products must meet WHO Prequalification standards. WHO PQ status affects which HS codes are eligible for preferential procurement pricing and duty exemptions in recipient countries.

Country-Specific Registration

Each destination country requires product registration before import. Key markets like Brazil and Cayman Islands have specific pharmaceutical regulatory bodies that must approve the product before customs clearance.

Related Advanced Oncology — Products Sharing Similar HS Codes

Other products in the Advanced Oncology therapeutic category that may share HS code classifications with Daratumumab

actinomycin anastrozole axitinib

Tariff Schedule — Top Markets

TransData Nexus Daratumumab HS code trade compliance intelligence

1Tariff Schedule — Top Markets

Daratumumab is primarily classified under HS code 30021500, which pertains to immunological products, including monoclonal antibodies. The Most Favored Nation (MFN) tariff rates for this HS code vary among the top importing countries:

Brazil: The MFN tariff rate for HS 30021500 is 2%. Brazil has a preferential trade agreement with India under the India-MERCOSUR Preferential Trade Agreement, which may offer reduced tariffs on certain pharmaceutical products. However, specific details regarding Daratumumab would require consultation with the Brazilian customs authority.

Cayman Islands: As a British Overseas Territory, the Cayman Islands generally apply the UK's tariff schedule, which often includes low or zero tariffs on pharmaceutical products. Specific rates should be confirmed with the Cayman Islands Customs and Border Control.

Oman: Oman applies an MFN tariff rate of 5% on pharmaceutical products under HS 30021500. Oman and India are both members of the South Asian Free Trade Area (SAFTA), which may provide preferential rates; however, the applicability to Daratumumab should be verified with Omani customs authorities.

Zimbabwe: Zimbabwe's MFN tariff rate for HS 30021500 is 0%, reflecting its policy to exempt essential medicines from import duties. There is no specific preferential trade agreement between Zimbabwe and India affecting this product.

Classification Disputes & Misclassification Risks

TransData Nexus Daratumumab HS code trade compliance intelligence

1Classification Disputes & Misclassification Risks

Daratumumab, as a monoclonal antibody, is typically classified under HS code 30021500, designated for immunological products. However, misclassification can occur, particularly between HS codes 3003 and 3004:

HS 3003: This code covers medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not put up in measured doses or forms for retail sale.

HS 3004: This code includes medicaments put up in measured doses or forms for retail sale.

Common errors involve misclassifying Daratumumab under HS 3003 when it is packaged for retail sale, which should correctly fall under HS 3004. Such misclassifications can lead to incorrect duty assessments and potential customs penalties. Our data indicates that 99.6% of Daratumumab shipments are correctly classified under HS 30021500, reflecting a high compliance rate. Nonetheless, vigilance is necessary to maintain this standard and avoid penalties associated with misclassification.

TransData Nexus Research · WTO tariff schedules, WCO classification, pharmacopoeia standardsMar 2026

Pharmacopoeia & Quality Standards

TransData Nexus Daratumumab HS code trade compliance intelligence

1Pharmacopoeia & Quality Standards

As of the latest available information, Daratumumab does not have specific monographs in the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), or Indian Pharmacopoeia (IP). In the absence of official monographs, manufacturers typically adhere to internal quality standards and guidelines provided by regulatory authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).

Quality control measures for Daratumumab include:

Purity and Assay Requirements: Ensuring the monoclonal antibody meets high purity levels, typically exceeding 98%, and verifying the correct protein sequence and structure.

Dissolution Testing: While not standard for injectable biologics like Daratumumab, solubility and stability in solution are critical parameters assessed during formulation development.

Stability Testing: Conducted in accordance with International Council for Harmonisation (ICH) guidelines, considering different climatic zones to ensure product stability under various environmental conditions.

Manufacturers are advised to consult the latest regulatory guidelines and collaborate with relevant authorities to ensure compliance with all quality and safety standards for Daratumumab.

Frequently Asked Questions — Daratumumab HS Codes

Common questions about Daratumumab trade classification, answered with data from Indian Customs records.

What is the HS code for Daratumumab exports from India?

The most commonly used HS code for Daratumumab exports from India is 30021500 (Immunological products, put up in measured doses or for retail sale), which accounts for 99.6% of all Daratumumab trade valued at $349.5M. In total, India exports Daratumumab under 14 distinct HS code classifications.

How many HS codes are used for Daratumumab trade?

Daratumumab is exported from India under 14 different HS code classifications, covering a total trade value of $350.8M across 284 shipments. The top 5 HS codes account for 100.0% of total trade.

What is HS code 30021500?

HS code 30021500 refers to "Immunological products, put up in measured doses or for retail sale" under Chapter 30 (Pharmaceutical Products) of the Harmonized System. For Daratumumab, this code covers $349.5M in trade value with 61 transactions, 12 suppliers, and 13 buyers across 13 countries. The average unit price under this code is $47667.37.

What is the difference between HS 30021500 and 30049099 for Daratumumab?

HS 30021500 (Immunological products, put up in measured doses or for retail sale) accounts for 99.6% of Daratumumab trade ($349.5M) with an average unit price of $47667.37, while HS 30049099 (Other medicaments, put up in measured doses or for retail sale) covers 0.3% ($882.2K) at $1237.26 per unit. HS 30021500 involves 12 suppliers and 13 buyers, compared to 43 suppliers and 50 buyers for HS 30049099.

Official References & Regulatory Resources

HS code classifications follow the WCO Harmonized System. Verify tariff rates with your national customs authority.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Daratumumab

Daratumumab

Top Daratumumab HS Code Classifications

All Daratumumab HS Code Classifications

Top Suppliers

Related Analysis

Need HS Code Reports?

Where Daratumumab is Exported — Geographic HS Code Analysis

Understanding Daratumumab HS Codes

How Daratumumab HS Codes Work

Regulatory & Compliance — Daratumumab Export Classification

Import Duty Classification

DGFT & Indian Customs Requirements

WHO Prequalification

Country-Specific Registration

Related Advanced Oncology — Products Sharing Similar HS Codes

Tariff Schedule — Top Markets

1Tariff Schedule — Top Markets

Classification Disputes & Misclassification Risks

1Classification Disputes & Misclassification Risks

Pharmacopoeia & Quality Standards

1Pharmacopoeia & Quality Standards

Frequently Asked Questions — Daratumumab HS Codes

What is the HS code for Daratumumab exports from India?

How many HS codes are used for Daratumumab trade?

What is HS code 30021500?

What is the difference between HS 30021500 and 30049099 for Daratumumab?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

How much Daratumumab is exported under HS code 30021500?

Which countries import the most Daratumumab from India?

Who are the top Daratumumab exporters from India?

Analysis Methodology